ID: ALA1923953

Max Phase: Preclinical

Molecular Formula: C6H7MgO9P

Molecular Weight: 256.10

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1O[C@H]([C@@H](O)CO)C(O)=C1OP(=O)([O-])[O-].[Mg+2]

Standard InChI:  InChI=1S/C6H9O9P.Mg/c7-1-2(8)4-3(9)5(6(10)14-4)15-16(11,12)13;/h2,4,7-9H,1H2,(H2,11,12,13);/q;+2/p-2/t2-,4+;/m0./s1

Standard InChI Key:  ACFGRWJEQJVZTM-LEJBHHMKSA-L

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 256.10Molecular Weight (Monoisotopic): 255.9984AlogP: -1.86#Rotatable Bonds: 4
Polar Surface Area: 153.75Molecular Species: ACIDHBA: 7HBD: 5
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 0.81CX Basic pKa: CX LogP: -2.57CX LogD: -9.28
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.29Np Likeness Score: 2.34

References

1. Kato E, Sasaki Y, Takahashi N..  (2011)  Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants.,  19  (21): [PMID:21945458] [10.1016/j.bmc.2011.08.067]

Source